CARLOTA TOMPKINS: Open Payments
NPI 1255012282 · BEDFORD HILLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,819 in 60 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $204 · 2025 $1,819
Food & beverage: $1,777Education: $42
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $257 |
| Lilly USA, LLC | 7 | $236 |
| Otsuka America Pharmaceutical, Inc. | 10 | $223 |
| Novo Nordisk Inc | 5 | $207 |
| Madrigal Pharmaceuticals | 1 | $148 |
| AstraZeneca Pharmaceuticals LP | 3 | $142 |
| Indivior Inc. | 4 | $102 |
| Amneal Pharmaceuticals LLC | 2 | $99 |
| Collegium Pharmaceutical, Inc. | 4 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
Products named: VRAYLAR, REXULTI, REZDIFFRA, AIRSUPRA, Ozempic, MOUNJARO, SUBLOCADE, CREXONT.
Industry payments across NY — which companies pay providers there.
